6
2
↑0
↓6
—2
Evidence suggests Melatonin maydecreaseInsomnia.
12 studies (8 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
11 of 12
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| melatonin | Decreases - has shown promising results | insomnia | Human | children with ASD | Not specified | Epidemiology and management of insomnia in children with autistic spectrum disorders.cited 43× |
| melatonin | No effect - might be beneficial | insomnia | Human | patients with Parkinson's disease | Not available | Treatment of the sleep disorders associated with Parkinson's disease.cited 38× |
| melatonin | No effect - efficacy | insomnia | Human | adults and children | Not specified | The use and misuse of exogenous melatonin in the treatment of sleep disorders.cited 21× |
| melatonin | No effect - little scientific evidence is available that supports any benefit of | insomnia | Human | — | Not specified | Melatonin in sleep disorders.cited 14× |
| melatonin | Decreases - improving | insomnia | Human | atopic dermatitis patients | Not specified | Clinical Pearls on Sleep Management in Atopic Dermatitis.cited 9× |
| melatonin | No effect - can be administered orally, which has led to interest in its use as a treatment for | insomnia | Human | — | — | Melatonin in sleep disorders.cited 48× |
| Melatonin | Decreases - may demonstrate effectiveness in addressing insomnia | insomnia | Human | — | Not specified | Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches.cited 14× |
| melatonin | Decreases - indicates long-term efficacy and safety | insomnia | Human | pediatric settings | Not specified | Insomnia in children affected by autism spectrum disorder: The role of melatonin in treatment.cited 2× |
| melatonin | No effect - had more substantive evidence | insomnia | Human | older adults | Not specified | A scoping review of over-the-counter products for depression, anxiety and insomnia in older people.cited 2× |
| Melatonin | Decreases - further intervention | insomnia | Human | Parkinson's disease patients | Not specified | Pharmacological and non-pharmacological management of sleep disturbances in Parkinson's disease: if when and how. |
| melatonin | Decreases - some efficacy data have been reported | insomnia | Human | patients with cancer | Not specified | Proposal for Managing Cancer-Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of Treatment.cited 2× |